US EditionRFK Jr. and Other Trump Officials Embrace Psychedelics After FDA Setback
UNITED STATES, JUL 16 – RFK Jr. aims to fast-track psychedelic therapies for conditions like PTSD and addiction, with Texas approving $50 million for ibogaine research, officials said.
- Last month, Texas allocated $50 million to research the use of ibogaine, a powerful psychedelic derived from a West African shrub, for addressing opioid dependence, PTSD, and additional health issues.
- This funding follows decades of advocacy and recent federal setbacks, including the FDA rejecting MDMA for PTSD and regulators calling for new, lengthy studies.
- Veterans and groups like Veterans Exploring Treatment Solutions have lobbied extensively, helping over 1,000 veterans access ibogaine and other psychedelics abroad.
- A senior health official indicated that efforts are underway to make these treatments accessible within a year, while cautioning that it is important to remain objective and avoid generating excessive excitement without thorough evaluation.
- Officials in Washington and some states, including Texas, Oregon, and Colorado, are advancing psychedelic research, suggesting cautious optimism amid concerns about safety and regulatory pace.
89 Articles
89 Articles
RFK Jr., other Trump officials push to green-light psychedelic therapy
Washington — For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions.
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions.
Robert F. Kennedy Jr. and other Trump officials embrace psychedelics after FDA setback
WASHINGTON — For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions. A presidential administration finally seems to agree. “This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure th…
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium
